Skip to search formSkip to main contentSkip to account menu

YM753

National Institutes of Health

Related topics

Related topics

1 relation
OBP-801

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model.
Histone deacetylase (HDAC) inhibitors have been shown to have antitumor activity in vitro and in vivo. Various studies related to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)